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Polycomb (PcG) and Trithorax (TrxG) group proteins act
antagonistically to establish tissue-speciﬁc patterns of gene
expression. The PcG protein Ezh2 facilitates repression by
catalysing histone H3-Lys27 trimethylation (H3K27me3).
For expression, H3K27me3 marks are removed and replaced
by TrxG protein catalysed histone H3-Lys4 trimethylation
(H3K4me3). Although H3K27 demethylases have been iden-
tiﬁed, the mechanism by which these enzymes are targeted
to speciﬁc genomic regions to remove H3K27me3 marks has
not been established. Here, we demonstrate a two-step
mechanism for UTX-mediated demethylation at muscle-spe-
ciﬁc genes during myogenesis. Although the transactivator
Six4 initially recruits UTX to the regulatory region of muscle
genes, the resulting loss of H3K27me3 marks is limited to
the region upstream of the transcriptional start site.
Removal of the repressive H3K27me3 mark within the
coding region then requires RNA Polymerase II (Pol II)
elongation. Interestingly, blocking Pol II elongation on
transcribed genes leads to increased H3K27me3 within the
coding region, and formation of bivalent (H3K27me3/
H3K4me3) chromatin domains. Thus, removal of repressive
H3K27me3 marks by UTX occurs through targeted recruit-
ment followed by spreading across the gene.
The EMBO Journal (2010) 29, 1401–1411. doi:10.1038/
emboj.2010.37; Published online 18 March 2010
Subject Categories: chromatin & transcription; differentiation
& death
Keywords: chromatin; histone demethylase; myogenesis;
transcription; UTX
Introduction
Tissue-speciﬁc patterns of gene expression are established
through the antagonistic functions of Polycomb group (PcG)
and Trithorax group (TrxG) proteins (Ringrose and Paro,
2004; Brock and Fisher, 2005; Muller and Verrijzer, 2009).
Although several enzymatic activities have been identiﬁed in
both the PcG and TrxG groups of proteins (Ringrose and Paro,
2004; Brock and Fisher, 2005), a hallmark of their function
seems to be the ability to methylate histones at speciﬁc
genomic loci—the PcG protein Ezh2 (KMT6) marks repres-
sive chromatin by trimethylation of histone H3 Lys 27
(H3K27me3), whereas the KMT2 family of TrxG proteins
mark transcriptionally active chromatin by trimethylation of
histone H3 Lys 4 (H3K4me3). In addition, genome-wide
studies of chromatin states have revealed the existence of
bivalent—H3K4me3 and H3K27me3—chromatin domains
that mark developmentally regulated genes that are not
actively transcribed (Bernstein et al, 2006). Although initially
identiﬁed in pluripotent cells, bivalent chromatin domains
have also been shown to be present at developmentally
regulated genes in cells of restricted potency, including
terminally differentiated cells (Mohn et al, 2008). The fact
that bivalently marked genes are not expressed suggests that
the repressive effects of H3K27me3 dominate over the acti-
vating effects of H3K4me3 when both marks are present
(Barski et al, 2007). As the repressive H3K27me3 mark can
be heritably transmitted to daughter cells to maintain speciﬁc
gene expression programs (Hansen et al, 2008), expression of
developmentally regulated genes would require the removal
of the H3K27me3 mark to permit the activation of gene
expression. The identiﬁcation of UTX (KDM6A) and JMJD3
(KDM6B) as proteins that mediate demethylation of
H3K27me3 provided insight into the mechanism by which
promoters could transition from a transcriptionally repressed
to a transcriptionally active state (Agger et al, 2007; De Santa
et al, 2007; Hong et al, 2007; Lan et al, 2007; Lee et al, 2007;
Chaturvedi et al, 2009). Proteomics analysis has shown
that UTX complexes with MLL3/HALR(KMT2C), MLL4/
ALR(KMT2D), and PTIP (Cho et al, 2007; Issaeva et al,
2007; Lee et al, 2007). However, the mechanism by which
the H3K27 demethylases are targeted to subsets of genes in a
tissue-speciﬁc manner has not been established.
During development, expression of myogenin (Myog) is
restricted to cells of the skeletal muscle lineage, whereas
muscle creatine kinase (CKm) is restricted to cells of the
skeletal and cardiac muscle lineages. These two genes repre-
sent an excellent model for studying tissue-speciﬁc gene
expression as their activation is temporally distinct during
myogenesis (Bergstrom et al, 2002). As would be expected of
genes that demonstrate muscle-speciﬁc gene expression, both
of these loci have polycomb-associated H3K27me3 marking
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1401of nucleosomes in human embryonic ﬁbroblasts (Bracken
et al, 2006). Similarly, it has been shown that the CKm gene is
targeted by the PcG protein Ezh2 in muscle progenitor cells
leading to an enrichment of the H3K27me3 repressive chro-
matin mark at this locus (Caretti et al, 2004). Upon myogenic
differentiation, H3K27me3 is lost at the CKm gene (Caretti
et al, 2004) and both the Myog and CKm genes become
marked by TrxG-mediated H3K4me3 permitting gene expres-
sion (Rampalli et al, 2007). In this study, we sought to
decipher the mechanism by which demethylation of
H3K27me3 is mediated at the muscle-speciﬁc Myog and
CKm genes during myogenesis.
Results
Demethylation of muscle genes occurs through
a two-step process
Native chromatin immunoprecipitation (ChIP) (Brand et al,
2008) was used to proﬁle the distribution of PcG-mediated
H3K27me3 and TrxG-mediated H3K4me3 across the Myog
and CKm genes (Figure 1) during serum withdrawal-induced
differentiation of C2C12 myoblasts (Yaffe and Saxel, 1977). To
compare enrichment of histone modiﬁcations at different
genomic positions, qPCR ampliﬁcations with each primer
set were normalized using genomic DNA. Paralleling gen-
ome-wide studies that have demonstrated H3K27me3 marks
chromatin over extended chromatin domains (Barski et al,
2007), we observe extensive enrichment of H3K27me3
throughout the 50 regulatory region, and the coding region
of the CKm and Myog genes in proliferating (0h) myoblasts,
whereas H3K4me3 levels remain relatively low at these
repressed loci (Figure 1B and C, top panel). By 24h of
differentiation, the Myog gene is expressed (Rampalli et al,
2007; see Figure 6B) and demonstrates extensive loss of
H3K27me3 across the 50 regulatory region and portions of
the coding region (but not at the 30 UTR), whereas the 50
end of the coding region becomes enriched for H3K4me3
(Figure 1B, middle panel). In contrast, the CKm gene (which
is transcriptionally silent at 24h (Rampalli et al, 2007; see
Figure 6B) remains enriched for H3K27me3 across the loci
with the exception of Region 2, which represents its upstream
muscle-speciﬁc enhancer (Figure 1C, middle panel). This loss
of H3K27me3 at the enhancer position is not caused by
reduced nucleosome occupancy (Schones et al, 2008) or
nucleosome instability (Jin et al, 2009) as histone H3 remains
associated with the CKm enhancer throughout differentiation
(Supplementary Figure 1B). By 48h of differentiation, both
Myog and CKm are expressed at high levels (Rampalli et al,
2007; see Figure 6B), and display extensive loss of H3K27me3
both within the coding region and as far upstream as  10 kb
of the gene (Figure 1B and C, bottom panels). This is
accompanied by enrichment of H3K4me3 within the gene
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Figure 1 Methylation of histone H3 at the Myog and CKm genes during muscle differentiation. (A) Schematic representation of the Myog and
CKm genes. P represents gene promoters, whereas E in the CKm gene represents enhancer (distal and intronic) elements. The encircled
numbers above the schematic indicate the location on the gene where each of the different probe sets localize for analysis of ChIP studies.
(B, C) Native ChIP analysis of the temporal (0, 24, and 48h) changes in H3K27me3 or H3K4me3 enrichment across the Myog and CKm genes.
Chromatin isolated from C2C12 cells at various stages of differentiation was subjected to immunopuriﬁcation using either an anti-H3K27me3 or
an anti-H3K4me3 antibody. After deproteination, immunopuriﬁed DNA was quantitated by qPCR using probes that recognize the different
regions indicated in the schematic in Figure 1A.
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reduced but continued enrichment of the repressive
H3K27me3 mark in the 30 end of both the expressing myog
and CKm genes. The importance of retaining the H3K27me3
mark in this region is not clear but its position suggests a
possible function in transcript processing. Thus, expression
of both the Myog and CKm genes are regulated through the
antagonistic methylation activities of polycomb (H3K27me3)
and trithorax (H3K4me3) group proteins. In addition,
demethylation at the CKm gene seems to occur in two
temporally distinct steps.
The demethylase UTX mediates removal of H3K27me3
at the Myog and CKm genes
Demethylation of H3K27me3 in mammalian cells has been
shown to be mediated through the activity of the enzymes
JMJD3 and UTX (Agger et al, 2007; De Santa et al, 2007; Hong
et al, 2007; Lan et al, 2007; Lee et al, 2007). Although JMJD3
seems to have a global function in modulating H3K27me3
levels in the cell, ectopic expression of UTX has only modest
effects on cellular levels of this repressive histone mark
(Agger et al, 2007; Lan et al, 2007), suggesting it could be
acting to demethylate-speciﬁc genomic loci. ChIP analysis
demonstrates recruitment of UTX to the transcriptional
regulatory region of both the Myog and CKm genes at 24h
(Figure 2A and B, Myog Region 3 and Ckm Region 2). This
recruitment of UTX coincides with a loss of the antagonistic
Ezh2 H3K27 methyltransferase enzyme (Figure 2A) and
removal of the repressive H3K27me3 mark at both genes
(Figure 1B and C). Ash2L1 (the primary Ash2L isoform
expressed in differentiating C2C12 cells; see Supplementary
Figure 2) is maximally enriched at both genes by 48h
(Figure 2A), coinciding with the increased enrichment of
H3K4me3 within their respective coding regions (Figure 1B
and C). This differential temporal recruitment of Ash2L1 and
UTX to muscle-speciﬁc genes is consistent with earlier results
examining the binding of these two proteins to the HoxA1-3
and HoxB1-3 genes in differentiating NTERA2 cells (Lee et al,
2007), and supports our earlier ﬁndings that Ash2L1/
MLL2(KMT2B) establishes this transcriptionally permissive
H3K4me3 mark at muscle-speciﬁc genes (Rampalli et al,
2007). Interestingly, we see the recruitment of UTX at 24h
(Figure 2B, Ckm Region 4) to the previously described
intronic enhancer of the CKm gene (Johnson et al, 1989),
though we do not see demethylation of H3K27me3 within
this region. It is unclear why UTX is unable to demethylate
H3K27me3 at this location, but suggests that the activity of
this enzyme could be modulated through other epigenetic
markings of chromatin. This observation is consistent with
studies of the Hox locus demonstrating UTX is enriched in
multiple regions that remain marked by H3K27me3 (Lan
et al, 2007). By 48h of differentiation, UTX is enriched across
the coding region of both the Myog and CKm genes
(Figure 2B) and can be detected at regions of the gene that
demonstrate loss of the repressive H3K27me3 mark (Figure 1B
and C). To conﬁrm a function for UTX in mediating the
demethylation of these two muscle-speciﬁc genes, we per-
formed shRNA-mediated knockdown of this protein using
lentiviral constructs (Figure 3A). Knockdown of UTX in differ-
entiating myoblasts leads to an marked decrease in both Myog
and CKm expression while having no effect on expression
levels of the ubiquitously expressed DDX5 gene (Figure 3B and
data not shown). Furthermore, immunocytochemistry experi-
ments demonstrate that knockdown of UTX in C2C12 cells
prevents the formation of multinucleated, myosin heavy chain
(MHC) positive myotubes (Figure 3C). Concomitant with the
loss of expression, knockdown of UTX in differentiating myo-
blasts inhibits demethylation of H3K27me3 at both the CKm
and Myog genes (Figure 3D), but has no effect on the
transcriptionally silent HOXB8 promoter that is bivalently
marked in C2C12 cells (Bernstein et al, 2006). Thus, UTX is
responsible for removing the repressive H3K27me3 mark at
the Myog and CKm genes during myogenesis, though we note
that the relative distribution of the H3K27 demethylase across
the Myog and CKm loci (Figure 2B; 48h differentiation)
suggests that different mechanisms may exist for establishing
demethylation of the distinct regions across the genes.
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Figure 2 UTX becomes associated with the Myogenin and CKm loci
during C2C12 myogenesis. (A) Cross-linked chromatin from C2C12
cells (growing (0h) or differentiated (24 or 48h)) was subject to
ChIP analysis using antibodies directed against UTX, Ezh2, or
Ash2L. Immunopuriﬁed DNA was quantitated by qPCR using
probes that recognize either the Myog promoter (left panel) or the
distal enhancer of the CKm gene (right panel). To account for
variability in IP efﬁciency of the three different antibodies, relative
enrichment is plotted as a percentage of the maximal enrichment
value observed for each factor individually during the 48h time
course after ﬁrst calculating the absolute enrichment as a percen-
tage of input chromatin. (B) X-ChIP analysis of the temporal (0, 24,
and 48h) changes in UTX enrichment across the Myog and CKm
genes. Chromatin isolated from C2C12 cells at various stages of
differentiation was subjected to immunopuriﬁcation using an anti-
UTX antibody. After deproteination, immunopuriﬁed DNA was
quantitated by qPCR using probes that recognize the different
regions indicated in the schematic in Figure 1A.
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myogenesis
The localized demethylation of the CKm enhancer at 24h of
differentiation suggests that UTX is targeted to speciﬁc genes
through an interaction with transactivators. Among the tran-
scriptional regulators known to associate with the Myog
promoter, we observed an association between UTX and the
homeobox protein Six4 in reciprocal immunoprecipitations
using nuclear extracts prepared from C2C12 cells that had
been differentiated for 24h (Figure 4A). Further conﬁrming
this interaction, UTX and Six4 co-immunoprecipitate from
nuclear extracts prepared from human erythroleukemia
(K562) cells that also express both proteins endogenously
(Figure 4B). ChIP experiments demonstrate that Six4 is
recruited to the regulatory region of both Myog and CKm at
24h of differentiation (Figure 4C; Supplementary Figure 3),
when UTX is strongly associated with these genes (Figure 2).
Consistent with its previously described function in regulat-
ing transcription of the Myog and CKm genes (Spitz et al,
1998; Himeda et al, 2004), we observe that a 70% knock-
down of Six4 in differentiating myoblasts results in a similar
decrease in both Myog and Ckm gene expression, without
affecting UTX, Myostatin, or global H3K27me3 levels (Figure
4D and E). This decreased expression of muscle-speciﬁc
genes in the absence of Six4 coincides with a decrease in
UTX recruitment to the regulatory regions of both the Myog
and CKm (Figure 4F), and results in an increased enrichment
of the repressive H3K27me3 mark at these genes (Figure 4G).
Taken together, these results demonstrate that Six4 facilitates
expression of muscle-speciﬁc genes by recruiting UTX to their
regulatory region.
Recruitment of Ash2L1/MLL2(KMT2B)-containing H3K4
methyltransferase complexes to muscle-speciﬁc promoters
by Mef2d requires phosphorylation of the transactivator by
p38 MAPK (Rampalli et al, 2007). Here, we used the phar-
macological inhibitor SB203850 to determine whether Six4-
mediated recruitment of UTX to the Myog and CKm genes is
also p38 MAPK dependent. ChIP analysis demonstrated that,
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Figure 3 UTX mediates removal of the H3K27me3 mark at the Myog and CKm genes during myogenesis. (A) Western blot analysis of UTX
knockdown in differentiating C2C12 cells. Nuclear extracts prepared from cells infected with lentivirus expressing shRNA that target UTX or
control (scrambled) were separated by SDS–PAGE and analysed by western blot using the antibodies indicated. Each panel represent two lanes
run on the same gel that have been cropped due to space constraints. Uncropped blots are shown in Supplementary Figure 7. (B) Gene
expression in C2C12 cells after UTX knockdown. Primers speciﬁc for Myog, CKm, or the ubiquitously expressed DDX5 mRNA were used to
amplify cDNA prepared from C2C12 cells under growth ( ) or differentiation (þ) conditions. Cells were infected with the non-targeted
scrambled shRNA (control) or an UTX-targeted shRNA as indicated. (C) C2C12 cells infected with control (scrambled) or UTX-targeted shRNA
were differentiated for 72h and then examined by immunocytochemistry for actin (phalloidin stain), Myog, or MHC, whereas the DNA was
stained with DAPI. Images were generated on a Zeiss 510 Confocal microscope using a  40 lens. (D) Native ChIP analysis measured relative
H3K27me3 levels at various regions within the Myog, CKm, or HoxB8 loci. C2C12 cells were infected with control (shRNA-scrambled) or UTX
(shRNA-UTX) targeting shRNA, selected for infection using puromycin and then differentiated for 72h. Positions on the locus correspond to
regions indicated in the schematic in Figure 1A.
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does not require p38 MAPK activity (Figure 5A). Consistent
with this observation, inhibition of p38 MAPK signalling did
not prevent the demethylation of H3K27me3 within the
transcriptional regulatory region of either Myog (Figure 5B,
Regions 2 and 3) or CKm (Figure 5B, Regions 2 and 3) at 48h
of differentiation. In contrast, spreading of the demethylase
activity into the coding region of the gene was impaired at
both Myog and CKm in the presence of SB203580 (Figure 5B,
Myog Region 4 and CKm Regions 4 and 5). As we have
observed earlier (Rampalli et al, 2007), SB203580 prevented
Ash2L1 recruitment (Figure 5A) and H3K4me3 accumulation
(Figure 5B) on the Myog and Ckm genes. Thus, we examined
the effect of Ash2L knockdown on demethylation of the Myog
gene. Interestingly, the knockdown of Ash2L in differentiat-
ing C2C12 cells (Supplementary Figure 4A) leads to a similar
distribution of H3K27me3 at the Myog gene, where the
coding region of the gene remains enriched for the repressive
histone mark (Supplementary Figure 4B). This demonstrates
that an event downstream of Ash2L1 recruitment is necessary
for spreading of the UTX demethylase activity into the coding
region of these muscle genes.
Blocking of RNA Pol II elongation leads to the formation
of bivalent H3K27me3/H3K4me3 marks
Inhibition of p38 MAPK activity in differentiating myoblasts
leads to the formation of a transcriptionally poised promoter
that is enriched for RNA Polymerase II (Pol II) (Simone et al,
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Figure 4 Six4 targets UTX to muscle-speciﬁc genes. (A) Proteins were immunoprecipitated from C2C12 nuclear extracts (24h differentiation)
using antibodies directed against UTX, Myog, Six4, or control IgG. Immunoprecipitated proteins, and 1/50th of input, were examined by
western blot using the antibodies indicated. The left panel corresponds to an immunoprecipitation experiment, where the input and elution
samples were processed together. The blot was cropped to remove lanes corresponding to ﬂow-through fractions, and thus the input is
separated from the elution fractions by a white bar but was run on the same gel and has the same exposure. Uncropped versions of the UTX and
Six 4 analysis are shown in Supplementary Figure 6A. (B) Proteins were immunoprecipitated from nuclear extracts prepared from
erythroleukemia cell line K562 using antibodies directed against Six4, Mef2, or control IgG. Immunoprecipitated proteins, and 1/10th of
input, were examined by western blot using the antibodies indicated. The asterisk (*) marks a non-speciﬁc band observed from the UTX
antibody in K562 cells. Mef2/IgG indicates that the two Mef2 bands observed in K562 cells co-migrated with IgG. To provide evidence that the
stronger band observed in the Mef2 IP lane represents immunoprecipitated Mef2, we provide a shorter exposure of the blot in Supplementary
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higher than their counterpart in the input because the samples were eluted in a buffer containing urea. (C) Cross-linked chromatin from C2C12
cells (growing (0h) or differentiated (24h)) was subjected to ChIP analysis of Six4 binding. Immunopuriﬁed DNA was quantitated by qPCR
using hydrolysis probes that recognize Myog (Region 3), CKm (Region 2), or IgH. (D) Western blot analysis of protein extracts isolated from
cells infected with lentivirus expressing shRNA targeting Six4 or a scrambled control. Nuclear extracts prepared from cells infected with
lentivirus expressing shRNA that target UTX or control (scrambled) were separated by SDS–PAGE and analysed by western blot using the
antibodies indicated. Each panel represents two lanes run on the same gel that have been cropped due to space constraints. Uncropped blots
are shown in Supplementary Figure 8. (E) RNA isolated from cells infected with lentivirus expressing Six4 targeting (or control) shRNA was
reverse transcribed and subjected to qPCR analysis. Expression levels are expressed relative to DDX5. (F) Cross-linked chromatin from growing
( ), or 24h differentiated (þ) C2C12 cells was subjected to ChIP analysis using antibodies directed against UTX. Immunopuriﬁed DNA was
quantitated by qPCR using probes that recognize the promoter (Region 3) of Myog, or the upstream enhancer (Region 2) of CKm. (G) Native
chromatin from growing ( ), or 24h differentiated (þ) C2C12 cells was subject to ChIP analysis using antibodies directed against H3K27me3.
Immunopuriﬁed DNA was quantitated by qPCR using probes that recognize the promoter (Region 3) of the Myog gene, or the upstream
enhancer (Region 2) of CKm.
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shown to associate with Rpb1 and to co-localize with elon-
gating Pol II (Rpb1 phosphorylated at Ser2) on polytene
chromosomes (Smith et al, 2008). We therefore used the
pharmacological inhibitor of transcriptional elongation DRB
(Figure 6A) to examine whether UTX-mediated demethyla-
tion within the gene may require the elongating Pol II. As
expected, DRB treatment blocked expression of CKm and
Myog (Figure 6B), resulting in the accumulation of Pol II
within the 50 end of the genes (Figure 6C, Region 3). To
determine the effect of Pol II elongation on H3K27 demethy-
lase activity, H3K27me3 native ChIP was performed on
chromatin isolated from 48h differentiated C2C12 cells that
had been treated with DRB for 3h (added at time point 45h of
differentiation) or 24h (added at time point 24h of differ-
entiation) (Figure 6D). Under both conditions, DRB treatment
leads to a marked increase in H3K27me3 enrichment within
the Myog and CKm coding regions (Region 4) compared with
the control-treated cells. Remarkably, the increased levels of
H3K27me3 observed after DRB treatment are accompanied
by a loss of UTX within the coding region, but not the
regulatory regions, of the genes (Supplementary Figure 5A)
and an increased association of Ezh2 and Suz12
(Supplementary Figure 5B) within the genes demonstrating
the dynamic relationship between PcG and TrxG proteins at
developmentally regulated genes. Taken together, this data
strongly suggests that the demethylase activity of UTX
migrates into the coding region of the Myog and CKm
genes with elongating Pol II.
Interestingly, the enrichment of H3K27me3 at the Myog
and CKm genes after induced Pol II stalling (treatment with
DRB at time point 45h) did not coincide with a loss of the
active H3K4me3 mark from the same loci (Figure 6D), lead-
ing to the formation of an apparent bivalent (H3K27me3/
H3K4me3) chromatin domain. However, when DRB treat-
ment was initiated at 24h of differentiation, the formation
of the bivalent mark was restricted to the Myog gene
(Figure 6D, DRB addition 24h). The differential marking of
chromatin at Myog and CKm at this time point is remarkable
because the Myog gene is already transcribed before adding
DRB at 24h of differentiation, whereas the CKm gene has not
yet begun to be expressed at this stage of differentiation
(Figure 6B). Only after the CKm gene has begun transcribing
(DRB at 45h) can the bivalent mark be formed on this gene,
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for the formation of bivalent marks. Finally, to determine
whether the co-localization of H3K27me3 and H3K4me3
marks reﬂect true bivalent domains (as opposed to a mixed
population of cells that were differentially marked with one
of the two methylations), we performed native ChIP-ReChIP
analysis. Analysis of chromatin from cells treated with or
without DRB show that genes that harbour a stalled Pol II can
be marked by both H3K27me3 and H3K4me3 at the same
allele (Figure 6E). These results suggest that the formation of
bivalent domains occur through the stalling of Pol II at
transcribed genes.
Discussion
During myogenesis, the muscle-speciﬁc genes Myog and
CKm transition from a transcriptionally repressive state
of H3K27me3 marked chromatin to the transcriptionally
permissive state of H3K4me3 marked chromatin. In this
study, we demonstrate that the histone demethylase UTX is
recruited to these two muscle genes to remove the repressive
H3K27me3 mark. Although the H3K4 methyltransferases
MLL3(KMT2C) and MLL4(KMT2D) are core components of
the UTX complex (Cho et al, 2007; Issaeva et al, 2007; Lee
et al, 2007), we ﬁnd that Ash2L1/MLL2(KMT2B) is the major
methyltransferase mediating H3K4me3 at the Myog and CKm
genes (Figure 5; Rampalli et al, 2007). This is consistent with
recent results showing that MLL1(KMT2A)/MLL2(KMT2B),
but not MLL3(KMT2C)/MLL4(KMT2D), is responsible for
mediating H3K4 trimethylation at the Hox locus, though
both MLL family subsets affect gene expression within the
cluster (Wang et al, 2009). Importantly, we observe that UTX
associates with the enhancer regions of the CKm gene before
gene expression, leading to a localized demethylation of the
upstream regulatory element. Furthermore, extensive loss of
H3K27me3 is observed within the promoter region of the
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blocked in C2C12 cells using a p38 MAPK inhibitor (Simone
et al, 2004; Rampalli et al, 2007), or Ash2L knockdown
(Rampalli et al, 2007). This, combined with studies showing
that UTX associates with regions of the Hox gene cluster in
the absence of RNA Pol II (Lan et al, 2007), demonstrates that
the initial recruitment of UTX to muscle-speciﬁc genes is not
through direct association with the elongating polymerase.
Instead, we ﬁnd that removal of H3K27me3 from the Myog
and CKm genes occurs through a two-step process. In a ﬁrst
step, UTX is targeted to muscle-speciﬁc genes by the tran-
scriptional regulator Six4 resulting in a localized demethyla-
tion of the transcriptional regulatory region upstream of the
transcription start site. Once associated with a speciﬁc locus,
UTX spreads into the coding region of the genes via an
elongating polymerase-mediated mechanism. Taken together,
these results provide novel insight into the mechanism by
which UTX acts to remove the H3K27me3 mark over several
kilobases of sequence at speciﬁc loci.
We have demonstrated that the DNA-bound transcriptional
regulator Six4 is responsible for targeting UTX to the Myog
and CKm gene regulatory regions. The strength of the asso-
ciation suggests that the interaction may not be direct, and
could be mediated by TLE1, which was identiﬁed by yeast
two-hybrid as an interacting partner of UTX (Grbavec et al,
1999), and interacts with Six family of proteins to co-regulate
gene expression (Lopez-Rios et al, 2003). Alternatively, the
interaction could be modulated through a post-translational
modiﬁcation of Six4, as we have previously observed for the
association between Ash2L1/MLL2(KMT2B) and phosphory-
lated Mef2d (Rampalli et al, 2007). An essential function for
Six4 in the activation of both the Myog (Spitz et al, 1998;
Grifone et al, 2005) and CKm (Himeda et al, 2004) genes has
previously been established. Deletion of the Six4-binding
element in the promoter of the Myog gene abolished correct
expression of a transgenic reporter (Spitz et al, 1998),
whereas similar studies with a mutant Six4-binding site in a
CKm transgenic reporter demonstrated signiﬁcant loss of
expression in muscle (Nguyen et al, 2003). In addition, the
Six1/Six4 double knockout mice demonstrate general muscle
hypoplasia and a loss of Myog expression (Grifone et al,
2005). However, the mechanism by which Six4 participates in
the activation of transcription has not previously been estab-
lished. Our study suggests that the function of Six4 is to target
the UTX/KMT2D demethylase complex to muscle-speciﬁc
promoters to activate gene expression. This function for
Six4 in establishing tissue-speciﬁc gene expression is surpris-
ing, as expression of this homeobox protein is not limited to
muscle tissue (Ohto et al, 1998). Interestingly, Mef2d (which
is also expressed in multiple tissues) recruits the Ash2L1/
KMT2B complex to muscle-speciﬁc genes in a p38-MAPK-
dependent manner during myogenesis (Rampalli et al, 2007),
whereas the muscle-speciﬁc transcriptional activator MyoD
establishes a transcriptionally poised promoter at the Myog
gene (Pol II, p300, and acetylated histone H3 are all present)
in the absence of p38-MAPK activity (Simone et al, 2004;
Rampalli et al, 2007). MyoD has also been shown to recruit P-
TEFb to the Myog promoter to mediate phosphorylation of
Pol II at Ser2 (Giacinti et al, 2006). This co-operation between
the three families of transcription factors is consistent with
the fact that binding sites for Six4 and Mef2d are enriched at
MRF bound genes that become activated during myogenesis
(Blais et al, 2005). Thus, the tissue-speciﬁc transcriptional
regulator MyoD seems to establish a transcriptionally poised
promoter at speciﬁc genes, whereas transcriptional regulators
Six4 and Mef2d that are expressed in multiple tissues have a
function in recruiting TrxG proteins to overcome the repres-
sive effects of PcG proteins to permit gene expression. The
fact that Six4 and Mef2d expression is not limited to muscle
suggests that these two proteins could collaborate with other
tissue-speciﬁc transactivators to overcome the repressive
effects of PcG in other cell types.
Once targeted to muscle-speciﬁc genes by Six4, UTX seems
to migrate into the coding region of the genes with the
elongating Pol II. Examination of H3K27me3 enrichment
across the CKm locus at 24h (prior to expression of this
gene) clearly demonstrates a localized demethylation that
does not spread into the gene. Upon expression, the coding
region of this gene becomes extensively demethylated. In
addition, we observe that either pharmacological inhibition
of p38 MAPK activity, or a knockdown of Ash2L prevent
demethylation of the coding region (but not the regulatory
elements) of both Myog and CKm genes. The fact that these
conditions block Pol II from engaging in transcription at these
two genes (Simone et al, 2004; Rampalli et al, 2007) supports
the notion that UTX moves across their coding regions with
the elongating polymerase. Indeed, Smith et al (2008) have
previously shown an interaction between UTX and Pol II in
cell extracts, while also demonstrating that UTX co-localizes
with the elongating Pol II on polytene chromosomes in
Drosophila. This argument is strengthened by experiments
showing that DRB-induced stalling of Pol II at the Myog and
CKm genes leads to a loss of UTX-mediated H3K27me3
demethylation activity within the coding region of the gene.
There are many cases of transcription-related factors spread-
ing across the coding region of genes with Pol II, the RNA
processing machinery being a prime example (Pandit et al,
2008; Brookes and Pombo, 2009). In addition, it has been
shown that TrxG proteins (both Ash1 and Kismet) that
stimulate transcriptional elongation indirectly reduce levels
of H3K27 methylation within target genes (Papp and Muller,
2006; Srinivasan et al, 2008). Interestingly, we observe that
the 30 end of both the Myog and CKm genes are demethylated
to a lesser extent than the rest of the coding region of the
gene. As UTX associates with Pol II phosphorylated at Ser 2
(Smith et al, 2008), it is possible that the demethylase is lost
in this region as the elongating Pol II becomes dephosphory-
lated to permit transcriptional termination (Ahn et al, 2004;
Kim et al, 2004). Consistent with this possibility, we observe
reduced association of UTX with the 30 end of the Myog and
CKm genes (Figure 2). Taken together, these results suggest
that the demethylase activity of UTX moves into the coding
region of the Myog and CKm genes with elongating Pol II. We
have also observed that UTX demethylates the region located
10kb upstream of the CKm and Myog genes. Although it is
possible that UTX could spread away from the coding region
using intergenic transcription (Dye et al, 2006), divergent
transcription (Seila et al, 2008), or self-polymerization (Li
et al, 2009), the molecular mechanism through which UTX
mediates removal of the repressive H3K27me3 mark in this
distal region remains to be determined.
Bivalent (H3K4me3/H3K27me3) chromatin domains
mark developmentally regulated genes in both pluripotent
(Bernstein et al, 2006) and terminally differentiated cells
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elongation of Pol II at the transcribing Myog and CKm genes
leads to the formation of bivalent (H3K4me3/H3K27me3)
chromatin marks. This relationship between the formation
of bivalent marks and the presence of stalled Pol II is
interesting in the light of recent ﬁndings. Although the
importance of stalled Pol II in regulating gene expression
has been long appreciated (Bentley and Groudine, 1986;
Rougvie and Lis, 1988; Krumm et al, 1992, 1995), recent
studies in Drosophila (Muse et al, 2007; Zeitlinger et al, 2007)
have suggested that this process is more prevalent than
previously believed. In mesodermal tissue derived from
Drosophila embryos, 12% of genes have a stalled polymerase
(Zeitlinger et al, 2007). Among loci possessing a stalled Pol II,
the number of developmentally regulated genes is dispropor-
tionately high (Zeitlinger et al, 2007). Consistent with this
ﬁnding, inactive CpG-rich promoters that tend to be marked
by bivalent methylation at H3K4 and H3K27 marks have been
shown to be bound by Pol II (Mohn and Schubeler, 2009).
Surprisingly, in our studies, the formation of the bivalent
mark was restricted to genes that have previously been
transcribed. This need for gene expression to establish biva-
lent marks is consistent with expression arrays studies,
suggesting that tissue-speciﬁc genes are sporadically
expressed in pluripotent embryonic stem cells (Efroni et al,
2008). Furthermore, studies using global run-on sequencing
demonstrate that genes that have stalled Pol II express low,
but signiﬁcant levels of full-length transcripts (Core et al,
2008). On the basis of these ﬁndings, we propose that
bivalent chromatin domains are established through stalling
of Pol II at transcribed genes whose activity is modulated by
the antagonistic functions of PcG and TrxG proteins.
In conclusion, we have demonstrated that the histone
demethylase UTX is targeted to muscle-speciﬁc genes by
the transcriptional activator Six4 to mediate removal of the
repressive H3K27me3 mark during myogenesis. After initial
targeting of muscle-speciﬁc genes, we show that spreading of
H3K27me3 demethylase activity of UTX across the gene
requires an actively elongating polymerase. Thus, this work
provides novel insight into the mechanism by which UTX
mediates the removal of H3K27me3 marks over extended
distances at developmentally regulated genes.
Materials and methods
Antibodies
Commercial antibodies used in these studies include H3K4me3
(Abcam ab8580), H3K27me3 (Abcam ab6002), H3 antibody
(Millipore 06-755), Myog (Santa Cruz SC-576), Suz12 (Abcam
ab12073), Mef2 (Santa Cruz sc-17785, sc-13917), RPB1 (Abcam
ab5408), and Ezh2 (Zymed 36-6300). Antibodies directed against
Ash2L (Demers et al, 2007), TAF10 (Wieczorek et al, 1998), and
Spt3 (Brand et al, 1999) have been described earlier. The Six4
antibody against the full-length protein was generated in rabbits as
described earlier (Spitz et al, 1998) and puriﬁed by afﬁnity to the
cognate recombinant proteins (A.B. unpublished reagent). The
rabbit anti-UTX antibody was generated against a recombinant
His-tagged protein corresponding to amino acids 550–728 of human
UTX protein that was expressed in bacteria.
Cell culture
The mouse myoblast cell line C2C12 was maintained at o80%
conﬂuency in DMEM containing 10% FBS, and differentiated in
DMEM containing 2% horse serum, 10mg/ml insulin, and 10mg/ml
transferrin. Lentivirus expressing shRNA targeting UTX or Six4
(Sigma) were used to infect C2C12 cells as described earlier (Yoon
and Chen, 2008). Brieﬂy, C2C12 cells were infected with lentivirus
at 20% conﬂuency in growth media. Infected cells were then re-
infected 24h later with fresh lentivirus, and selection with
puromycin began 36h after the initial infection. Differentiation
was induced 48h after the start of the infection, and continued for
an additional 24–72h. Stalling of Pol II was induced by the addition
of 5,6-dichloro-1-b-D-ribobenzimidazole (Sehgal et al, 1976) (DRB)
at a ﬁnal concentration of 100mM to C2C12 cells. For p38 inhibition
studies, SB203580 was added to the differentiation media at a ﬁnal
concentration of 10mM as described earlier (Zetser et al, 1999).
Chromatin immunoprecipitation
Analysis of histone modiﬁcations was performed using native ChIP
as described earlier (Rampalli et al, 2007; Brand et al, 2008).
Association of transcriptional regulators with speciﬁc regions of the
genome was performed using X-ChIP as described earlier (Brand
et al, 2004). Chromatin from C2C12 cells (cross-linked using 1%
formaldehyde) was sheared using a Bioruptor (Diagenode) to
obtain a resolution of B400bp. Immunoprecipitated DNA was
subjected to qPCR analysis using hydrolysis probes (see Supple-
mentary data for Primer/Probe sequences). To determine relative
enrichment (Brand et al, 2008), qPCR ampliﬁcation of immunopre-
cipitated samples was normalized to genomic DNA for each primer
set individually. Normalized values obtained from a mock IP (IgG)
were subtracted from those observed in the speciﬁc IP, and then
corrected for sample variation through division by normalized
values observed from 1/50th of the input chromatin. Average values
of an experiment represent biological replicates that are displayed
with error bars corresponding to ±s.d. Each experiment was
performed at least twice, and yielded similar results.
Double chromatin immunoprecipitation (native ChIP-ReChIP)
Analysis of bivalent marks was performed using a native ChIP-
ReChIP method developed based on a previously established native
ChIP protocol (Rampalli et al, 2007; Brand et al, 2008). Nuclei were
isolated from 4 10
7 C2C12 cells treated with DRB (or vehicle), and
their chromatin was fragmented with MNase (Supplementary
Figure 5C). Nucleosomes were then isolated from the nuclei by
hydroxyapatite chromatography before immunopuriﬁcation with
antibodies recognizing H3K4me3 or rabbit IgG. After washing,
immunoprecipitated chromatin was eluted from the antibodies with
a buffer containing 5mM NaPO4 (pH 7.2), 600mM KCl, 0.5mM
EDTA, and 25mM DTT—note that a high concentration of DTT
(up to 100mM) does not disrupt the integrity of the nucleosomes
(Dorigo et al, 2004). The eluate was then subjected to hydro-
xyapatite chromatography, and immunoprecipitated with antibo-
dies recognizing H3K27me3 or mouse IgG. DNA recovered from the
second immunoprecipitation was subjected to qPCR analysis as
described earlier. Average values of an experiment represent
biological replicates that are displayed with error bars correspond-
ing to ±s.d. Each experiment was performed at least twice, and
yielded similar results.
Reverse-transcription qPCR assays
Random-primed cDNA prepared from total RNA was subjected to
duplex qPCR. Probes speciﬁc for Myog, CKm, or Acta1 were
labelled with 50 ﬂuorescein phosphoramidite and 30 black hole
quencher-1, whereas the control DDX5 (Su et al, 2007) speciﬁc
probe was labelled with 50 Joe NHS Ester and 30 Iowa Black FQ. In
experiments where DRB was used to block transcriptional elonga-
tion, duplex qPCR was performed with a 50Yakima Yellow/30Eclipse
Dark Quencher-labelled 18S rRNA primer/probe set (Eurogentec).
Relative expression was calculated using D(DCt) of the gene-speciﬁc
probes compared with the control (DDX5) gene-speciﬁc probe.
Co-immunoprecipitations
Nuclear extracts were prepared from differentiating C2C12 cells at
24h time point as described earlier (Dignam et al, 1983). Rabbit
polyclonal antibodies were attached to Protein A Dynabeads
(Invitrogen), and then incubated with 5mg of nuclear extract for
16h. Immunoprecipitated material was washed three times with
buffer D (20mM Hepes pH 7.6, 300mM KCl, 0.5mM EDTA, 10%
glycerol and 0.1% Nonidet-40), eluted in either 1  SDS loading
dye or a urea containing buffer (50mM Tris pH 8.3, 6M Urea, 5mM
EDTA, and 0.05% SDS), and then subjected to western blot analysis
using the indicated antibodies.
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Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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